In today's podcast, we will discuss a court case involving a leukemia patient from Jiangsu who got him into trouble by buying generic drugs from India via mail order.Lu Yong, a 46-year old exporter from Wuxi, in the eastern province of Jiangsu, will stand trial in a court in Yuanjiang,in the central province of Hunan, on charges of credit card-related fraud and sales of fake drugs.Lu was diagnosed with leukemia more than 10 years ago and was treated with Glivec, a patented drug made by Novartis.The Swiss company got a license to sell the medicine in China in 2002.The drug regimen costs 23,500 yuan a month and is not covered by China's health care insurance, meaning it is too expensive for many ordinary people.After spending hundreds of thousands of yuan on the medicine,Lu was close to be broke in 2004 when he came across an English-language article mentioning another leukemia drug, this one called Veenat,a much cheaper generic version of Glivec made in India.He bought 3,000 yuan worth of Veenat via mail order, and this helped his condition improve.Lu not only switched to the generic drug himself, but also started to help patients he met in an online forum buy it.For this, he was arrested in a crackdown on credit card fraud in Yuanjiang in August 2013.In July, he was charged with "disrupting management of credit cards" and sales of fake medications.Luo Jian, a prosecutor in Yuanjiang, told Caixin that any drug lacking a government license，even one made by a registered pharmaceutical company
在今天的播报中，我们将探讨的是一名来自江苏的白血病病人因通过邮件订购印度药品而陷入麻烦的事件。46岁的陆勇是一名江苏无锡的出口商，他将站在湖南沅江法庭的被告席上，理由是他涉嫌利用信用卡销售造假药物。陆在10年前被查出患有白血病，并进行了格列卫的治疗，这是一个由诺华制药有限公司出品的专利药物。这家瑞士公司于2002年拿到了在中国销售的许可证。使用这种药物每个月将花费2.35万元的医药费，并不在医保范畴之列，这就意味着一般家庭来无法负担高额的医药费。花费了十几万医药费以后，2004年，陆将近破产，就在那时他看到了一篇英文文章，上面介绍了另一种治疗白血病的药物，Veenat，这是一种更为低廉的格列卫药物，是由印度公司生产的。他通过邮件订购的方式购买了3000元的药物，在一个月之内，他的病情有所好转。路不仅更换了药物，他还帮助网上论坛中的病人购买药物。就因为此案，2013年，他因涉嫌信用卡诈骗而遭到沅江的拘捕。7月，他被指控违反信用卡管理制度，以及销售假药。沅江法官罗建告诉财新网说，任何未经政府许可，就算是注册的医药公司，
暂无注释
